Drug General Information
Drug ID
D0U2QT
Former ID
DIB020986
Drug Name
Src kinase inhibitor I
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529039]
Structure
Download
2D MOL
Formula
C22H19N3O3
InChI
InChI=1S/C22H19N3O3/c1-26-20-12-18-19(13-21(20)27-2)23-14-24-22(18)25-15-8-10-17(11-9-15)28-16-6-4-3-5-7-16/h3-14H,1-2H3,(H,23,24,25)
InChIKey
DMWVGXGXHPOEPT-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) mRNA of human RIP2 Target Info Inhibitor [529039]
KEGG Pathway NOD-like receptor signaling pathway
Neurotrophin signaling pathway
Shigellosis
Tuberculosis
NetPath Pathway IL4 Signaling Pathway
TNFalpha Signaling Pathway
Pathway Interaction Database Canonical NF-kappaB pathway
IL12-mediated signaling events
p75(NTR)-mediated signaling
Reactome NOD1/2 Signaling Pathway
p75NTR recruits signalling complexes
TAK1 activates NFkB by phosphorylation and activation of IKKs complex
Interleukin-1 signaling
activated TAK1 mediates p38 MAPK activation
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
WikiPathways TCR Signaling Pathway
FAS pathway and Stress induction of HSP regulation
Apoptosis-related network due to altered Notch3 in ovarian cancer
MAP kinase activation in TLR cascade
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TAK1 activates NFkB by phosphorylation and activation of IKKs complex
Signalling by NGF
TCR signaling
Interleukin-1 signaling
NOD pathway
References
Ref 529039Biochem J. 2007 Dec 15;408(3):297-315.The selectivity of protein kinase inhibitors: a further update.
Ref 529039Biochem J. 2007 Dec 15;408(3):297-315.The selectivity of protein kinase inhibitors: a further update.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.